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Background and purpose — Combining components from dif-
ferent manufacturers in total hip arthroplasty (THA) is common 
practice worldwide. We determined the proportion of THAs used 
in the Netherlands that consist of components from different 
manufacturers, and compared the revision rates of these mixed 
THAs with those of non-mixed THAs.   
Patients and methods — Data on primary and revision hip 
arthroplasty are recorded in the LROI, the nationwide popula-
tion-based arthroplasty register in the Netherlands. We selected 
all 163,360 primary THAs that were performed in the period 
2007–2014. Based on the manufacturers of the components, 4 
groups  were discerned: non-mixed THAs with components from 
the same manufacturer (n = 142,964); mixed stem-head THAs 
with different manufacturers for the femoral stem and head (n = 
3,663); mixed head-cup THAs with different head and cup manu-
facturers (n = 12,960), and mixed stem-head-cup THAs with  dif-
ferent femoral stem, head, and cup manufacturers (n = 1,773). 
Mixed prostheses were defi ned as THAs (stem, head, and cup) 
composed of components made by different manufacturers. 
Results — 11% of THAs had mixed components (n = 18,396). 
The 6-year revision rates were similar for mixed and non-mixed 
THAs: 3.4% (95% CI: 3.1w–3.7) for mixed THAs and 3.5% (95% 
CI: 3.4–3.7) for non-mixed THAs. Revision of primary THAs due 
to loosening of the acetabulum was more common in mixed THAs 
(16% vs. 12%).
Interpretation — Over an 8-year period in the Netherlands, 
11% of THAs had mixed components—with similar medium-
term revision rates to those of non-mixed THAs.
■
There is a discrepancy between what guidelines recommend 
and the practice of mixing implant components (stem, head, 
or cup) from different manufacturers in assembling a total 
hip replacement. National arthroplasty register data show that 
components from different manufacturers are often combined, 
contrary to the advice in the product guidelines for these com-
ponents. Mixed prostheses are defi ned as total hip arthroplas-
ties (THAs) (stem, head, and cup) composed of components 
made by different manufactures. Non-mixed prostheses are 
defi ned as prostheses made up from components produced 
by one and the same manufacturer. With very little published 
in the literature on the consequences of implanting mixed 
prostheses, there is a need for evaluation of large numbers of 
mixed and non-mixed prostheses. Such data can be obtained 
from national arthroplasty registers (Graves 2010). 
Mixing and matching of THA component brands is common 
worldwide. Surgeons may use various combinations of cups, 
heads, and stems made by different manufacturers. Using the 
National Joint Registry of England and Wales (NJR), Tucker 
et al. (2015) identifi ed over 90,000 cases in which mixing 
of components was recorded between 2003 and 2013. How-
ever, the manufacturers emphasize that their implants were 
not designed, tested, or validated to be combined. In addi-
tion, there is a liability issue. Legally, the advice is not ever 
to implant a mixed arthroplasty unless you have familiarized 
yourself with the manufacturer’s product compatibility infor-
mation (Michel 2009).
It has been hypothesized that mixing and matching of com-
ponents from different manufacturers can lead to adverse 
effects (Ljung et al. 1989, Barrack et al. 1993, Morlock et 
al. 2001,  Andrew et al. 2008, Higgs et al. 2013, Kurtz et al. 
2013). However, recent research from the NJR of England and 
Wales revealed that combining a cemented stem with a poly-
ethylene cup from a different manufacturer did not result in 
higher revision rates (Tucker et al. 2015).
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We determined the proportion of THAs used in the Neth-
erlands that consist of mixed components and examined the 
revision rate for mixed THAs. We compared this with revision 
rates for non-mixed THAs. We hypothesized that mismatch 
between stem, head, and cup would result in higher revision 
rates for mixed THAs than for non-mixed THAs.
Patients and methods
The Dutch Arthroplasty Register
The Dutch Arthroplasty Register (LROI) is a nationwide pop-
ulation-based registry that has information on joint arthroplas-
ties in the Netherlands since 2007. The LROI was initiated by 
the Netherlands Orthopedic Association (NOV), and almost 
all Dutch orthopedic surgeons are members of this society. 
The LROI is well-supported by these members, resulting in an 
inter-institutional database with a completeness of more than 
95% for primary THAs and 88% for hip revision arthroplasty 
(van Steenbergen et al. 2015).
Data collection
The LROI contains information on patient characteristics such 
as age, sex, and general health (ASA score), hospital of sur-
gery, type of surgery, date of surgery, fi xation, and prosthe-
sis characteristics. The acetabular cup, femoral stem, femoral 
head, and inlay component of the hip prostheses can be regis-
tered in the LROI. Stickers supplied by the manufacturer, con-
taining information on the implanted component, are attached 
to the registration form. Prosthesis characteristics are derived 
from an implant library within the LROI, which contains 
several core characteristics of all the prostheses used in the 
Netherlands since 2007, including the name and type of the 
prosthesis, the manufacturer, the material, and the head size 
of the hip prosthesis. The characteristics are supplied by all 
the implant manufacturers or distributors in the Netherlands. 
A primary THA is defi ned as the fi rst implantation of a hip 
prosthesis, to replace a hip joint. Hip revision arthroplasty is 
defi ned as any exchange (placement, replacement, or removal) 
of one or more components of the hip prosthesis, including 
head exchange (van Steenbergen et al. 2015). 
The vital status of all patients was obtained from Vektis 
(2015), the national insurance database on healthcare in the 
Netherlands. For the present study, we included all the patients 
who underwent a primary THA in a Dutch hospital, from the 
start of the registry in 2007 until 2014 (n = 171,255). Patients 
with unknown prosthesis components were excluded (n = 
4,711; 2.8%), as were cases with missing components (n = 
5,184; 3.0%). These excluded patients generally had simi-
lar patient and treatment characteristics, although a slightly 
higher proportion underwent THA for reasons other than 
osteoarthritis than in the study population. The median length 
of follow-up was 3.0 years, with a maximum of 8.0 years. 
Implant information
The category of mixed THAs was based on the manufacturer 
of the femur, the femoral head, and the acetabular component. 
Prostheses consisting of components from the same manu-
facturer were defi ned as non-mixed THAs (manufacturer A 
(femur) – manufacturer A (head) – manufacturer A (cup)). 
Mixed THAs were named after the manufacturer of the femo-
ral component. Prostheses consisting of an acetabulum and a 
femoral head from the same manufacturer, but a femur from a 
different manufacturer were defi ned as mixed stem-head THAs 
(A-B-B). Similarly, mixed head-cup THAs were defi ned as a 
femur and a femoral head from the same manufacturer com-
bined with an acetabulum from a different manufacturer (A-A-
B). A fourth category, mixed stem-head-cup THAs, consisted 
of THAs with a different manufacturer for all components 
(femur, femoral head, and acetabulum) or THAs with the same 
manufacturer for femur and acetabulum, but a different manu-
facturer for the femoral head (A-B-C or A-B-A) (Figure 1).  
In addition to the retrieved prosthesis information, we col-
lected demographic data on all patients who received a THA in 
the period 2007–2014 in the Netherlands (Table 1). There were 
3 age categories: < 60, 60–74, and ≥ 75 years. Overall physi-
cal condition of the patient was scored using the ASA score 
(I–IV). Diagnosis was categorized as osteoarthritis or non-
osteoarthritis (consisting of mainly acute fracture, osteone-
crosis, dysplasia, and late posttraumatic conditions). Previous 
operation of the same hip mainly involved osteosynthesis and 
osteotomy. Fixation of the hip was categorized as cementless, 
hybrid (where the acetabular component is implanted unce-
mented and the femoral component is implanted cemented), 
cemented, reversed hybrid (where the acetabular component is 
implanted cemented and the femoral component is implanted 
uncemented), or unknown. Head size was categorized as 
22–28 mm, 32 mm, 36 mm, or ≥ 38 mm. Hip arthroplasty 
articulation was differentiated based on the bearing surface 
of the head and the bearing surface of the inlay or monob-
lock cup, and categorized as ceramic-on-polyethylene (PE), 
metal-on-PE, metal-on-metal, ceramic-on-ceramic, or other. 
Period of surgery was divided into 2007–2009, 2010–2011, 
and 2012–2014. Reasons for revision were infection, peripros-
thetic fracture, symptomatic metal-on-metal bearing, disloca-
tion, loosening of the femoral or acetabular component, wear 
of the liner/cup, periarticular ossifi cation, or establishment of 
a Girdlestone situation.
  Component
 Stem   Head Cup  
  Non-mixed THA A A A
  Mixed stem-head THA A B B
  Mixed head-cup THA A A B
  Mixed stem-head-cup THA        A B C
  A B A 
Figure 1. Combinations of components used in assembling a non-
mixed or mixed THA, where A, B, and C represent different manufac-
turers.
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Statistics
The 4 groups of non-mixed, mixed stem-head, mixed head-
cup, and mixed stem-head-cup components were taken sepa-
rately and compared using chi-square test to test differences in 
patient and prosthesis characteristics, including manufacturer. 
Survival time (with 95% confi dence interval (CI)) was cal-
culated as the time from primary THA to fi rst revision arthro-
plasty for any reason (Nelissen et al. 1992), death of the 
patient, or January 1, 2015 (the end of follow-up). Standard 
survival analysis treats death simply as censored information, 
but this approach overestimates revision rates (Lacny et al. 
2015, Wongworawat et al. 2015). Thus, crude cumulative inci-
dence of revision was calculated using competing risk analy-
sis, where death was considered to be a competing risk. Crude 
revision percentages within 1 year and 6 years were estimated 
according to the mixed-component group. Furthermore, revi-
sion rates within 6 years according to the reason for revision 
were estimated for non-mixed THAs and mixed THAs. The 
mixed-THA group contained all the mixed THAs, including 
mixed stem-head THAs, mixed head-cup THAs, and mixed 
stem-head-cup THAs. Differences in revision rates were com-
pared using chi-square test. Crude and multivariable Cox pro-
portional hazards regression analyses were performed. Adjust-
ments were made for possible confounding variables, e.g. age 
at surgery, gender, ASA score, diagnosis (osteoarthritis vs. 
non-osteoarthritis), previous operation, fi xation, head diam-
Table 1. Demographic and clinical data on all patients who received a THA in the period 2007–2014 in the Nether-
lands (n = 161,360)
  Non-mixed Mixed stem- Mixed head- Mixed stem-
  THA head THA cup THA head-cup THA Total
  (n = 142,964) (n = 3,663) (n = 12,960) (n = 1,773) (n = 161,360)
  n    (%) n    (%) n    (%) n    (%) n    (%)
Age, years
   < 60 26,586 19 502 14 3,078 24 280 16 30,446 19 a
   60–74 75,156 53 1,743 48 6,436 50 875 50 84,210 52
   ≥ 75 40,891 29 1,412 39 3,421 26 611 35 46,335 29 
Sex
 Male  46,656 33 1,093 30 4,147 32 583 33 52,479 33 a
 Female 95,491 67 2,554 70 8,755 68 1,180 67 107,980 67
ASA score
 I 33,483 25 947 26 3,508 29 383 25 38,321 25 a
 II 85,068 63 1,973 55 6,846 57 977 64 94,864 62
 III–IV 16,745 12 ´686 19 1,772 15 161 11 19,364 13
Diagnosis
 Osteoarthritis  124,464  87 3,191 87 10,568 82 1,545 87 139,768 87 a
 Non-osteoarthritis 18,500 13 472 13 2,392 18 228 13 21,592 13
Previous operation
 No 127,244 94 3,225 90 10,815 87 1,559 94 142,843 93 a
 Yes 6,599 4.9 277 7.7 1,087 8.8 88 5.3 8,051 5.3
 Unknown 1,605 1.2 90 2.5 497 4.0 4 0.2 2,195 1.4
Fixation
 Cementless 92,150 65 747 20.5 4,135 33 1,464 91 98,496 62 a
 Hybrid 3,519 2.5 272 7.5 3,538 28 19 1.2 7,348 4.6
 Cemented 41,878 30 2,515 69 2,390 19 75 4.7 46,858 29
 Reversed hybrid 3,898 2.8 106 2.9 2,589 20 43 2.7 6,636 4.2
 Unknown 125 0.1 23 0.6 37 0.3 0 0.0 164 0.1 
Diameter of head 
 22–28 mm 53,543 38 2,806 77 7,523 58 509 29 64,381 40 a
 32 mm 59,911 42 293 8.0 4,011 31 1,193 67 65,408 41
 36 mm 26,302 18 232 6.3 1,343 10 35 2.0 27,912 17
 ≥ 38 mm 3,207 2.2 323 8.8 83 0.6 36 2.0 3,649 2.3
Articulation
 Metal-on-metal 6,411 4.5 87 2.4 16 0.1 0 0.0 6,514 4.0 a
 Metal-on-PE 48,107 34 1,957 54 3,672 28 134 7.7 53,870 33
 Ceramic-on-PE 66,704 47 1,245 34 7,417 57 1,551 89 76,917 48
 Ceramic-on-ceramic 11,962 8.5 349 9.6 1,275 9.9 52 3.0 13,638 8.5
 Other 7,913 5.6 12 3.3 447 3.5 3 0.2 8,375 5.2 
Period
   2007–2009 35,241 24 939 26 4,256 33 923 52 41,359 26 a
   2010–2011 37,907 27 1,452 40 3,814 29 748 42 43,921 27
   2012–2014 69,816 49 1,272 35 4,890 38 102 5.8 76,080 47 
a p < 0.0001. 
Numbers do not add up to total due to unknown or missing components.
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eter, articulation, and period of surgery, to discriminate inde-
pendent risk factors for revision. For all covariates added to the 
multivariate Cox proportional hazards regression analyses, the 
proportional hazards assumption was checked and met. Any 
p-values less than 0.05 were considered to be statistically sig-
nifi cant. All analyses were performed using SPSS 22.0.
Results
161,360 THAs were included in the analysis. 11% of those 
performed in the period 2007–2014 were composed of mixed 
components (n = 18,396). This included 2.3% with a mixed 
stem and head, 8.0% with a mixed head and cup, and 1.1% 
with a mixed stem, head, and cup (Table 1). 
Mixed stem-head THAs
Mixing of stem and head components from different manufac-
turers was found in 3,663 (2.3%) of the THAs. Almost 40% 
of the patients with a THA with a mixed stem and head were 
aged 75 years or older. A relatively large proportion of 22- to 
28-mm diameter head components (77%), cemented THAs 
(69%), and metal-on-polyethylene articulations (54%) were 
used in THAs with a mixed stem and head (Table 1). 
Mixed head-cup THAs
The most frequent combination of mixed components used 
in THA was between the femoral head and the acetabu-
lar component (n = 12,960; 8.0%), with a relatively large 
proportion of patients aged under 60 years. The number of 
mixed head-cup THAs remained relatively constant over the 
periods 2007–2009, 2010–2011, and 2012–2014. Similar to 
the mixing of stem and head, a relatively large proportion of 
22- to 28-mm diameter head components (58%) were used in 
head-acetabulum mixed THAs, while this group contained a 
relatively small number of cemented THAs (19%) (Table 1).
Mixed stem-head-cup THAs
Mixing of femur, femoral head, and cup was found in 1,773 
cases (1.1%). Most of these patients had a low ASA score (I or 
II in 89%) and no previous operations on the affected hip joint 
(94%). A relatively large proportion of 32-mm diameter head 
components (67%), ceramic-on-polyethylene articulations 
(89%), and cementless fi xations (91%) were used in THAs 
with mixed femur, femoral head, and acetabulum. In the most 
recent time period (2012–2014), only 102 patients received a 
THA with a mixed stem, head, and cup (Table 1). 
Manufacturers
The implanted THAs were manufactured by 21 different man-
ufacturers. The femoral stem components were manufactured 
by 16 different manufacturers, femoral head components by 
17, and the acetabular components by 19 companies. Manu-
facturers with more than 500 THAs (n = 8) are listed in Table 
2. For these manufacturers, the percentages of non-mixed 
implants varied between 65% (Link) and 98% (Mathys Medi-
cal). A mixed stem and head component (n = 3,663) varied 
from 0% (Stryker) to 15% (Link) between different manu-
facturers. Mixed femoral head and acetabular components 
manufactured by Mathys Medical  were rarely combined with 
acetabular components from other manufacturers (2%). Head-
cup mixing was more common in THAs with femoral stem 
and head components from the manufacturers Link (20%) 
and Wright Medical (16%). Mixing of femoral stem, femoral 
head, and cup was detected in 1,773 THAs, ranging from 0% 
(Stryker and DePuy J&J) to 5% (Smith and Nephew) (Table 
2). Many different combinations of manufacturers were seen 
in all the mixed-THA groups, with the most frequently used 
combinations of manufacturers being the same for mixed 
stem-head THAs and mixed head-cup THAs (Table 3).
Revision
The overall 1-year revision rates of non-mixed THAs and 
Table 2. Manufacturers of total hip prostheses represented in the groups with non-mixed or mixed compo-
nents (n = 161,360)
  Non-mixed Mixed stem- Mixed head- Mixed stem-
  THA head THA cup THA head-cup THA Total a
  (n = 142,964) (n = 3,663) (n = 12,960) (n = 1,773) (n = 161,360)
  n    (%) n    (%) n    (%) n    (%) n
Zimmer 38,883 89 403 0.9 4,388 10 53 0.1 44,837
Stryker 22,572 94 10 0.0 1,456 6.1 6 0.0 24,121
Biomet 28,649 94 221 0.7 1,272 4.2 295 1.0 30,664
Smith and Nephew 19,225 88 147 0.7 1,200 5.5 1,171 5.4 21,874
DePuy J&J 13,672 96 33 0.2 528 3.7 3 0.0 14,329
Link 11,826 65 2,734 15 3,659 20 30 0.2 18,370
Mathys Medical 6,016 98 23 0.4 108 1.8 17 0.3 6,199
Wright Medical 831 79 53 5.0 167 16 2 0.2 1,053
 a
 The total included prostheses with unknown or missing components.
A mixed prosthesis was categorized according to the manufacturer of the most distal component. 
Manufacturers with < 500 THAs are not shown. 
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mixed THAs for all causes were similar (1.3% (CI: 1.3–1.4) 
for non-mixed THAs and 1.4% (CI: 1.2–1.5) for mixed THAs). 
The overall 6-year revision rate for all causes was not signifi -
cantly different for non-mixed THAs and for mixed THAs 
(3.5% (CI: 3.4–3.7) for non-mixed THAs and 3.4% (CI: 3.1–
3.7) for mixed THAs). No statistically signifi cant differences 
were found between the mixed-component groups (Table 4).
Cumulative incidence of revision in the mixed-component 
groups showed no statistically signifi cant difference in revi-
sion rate, although the revision rate was somewhat lower in 
the fi rst years in the group with mixed stem-head components 
(Figure 2).
Revision of a primary THA due to loosening of the acetabu-
lum was more common in mixed THAs (16% for mixed THAs 
and12% for non-mixed THAs). Revision due to a symptom-
atic metal-on-metal bearing was less common in mixed THAs, 
although this was mainly due to the fact that the proportion 
of metal-on-metal THAs was much higher in the non-mixed-
component group (1.7% vs. 6.6%) (Table 5). 
The crude survival analysis showed that patients with a 
mixed stem-head THA had a lower risk of revision than those 
Table 3. The 5 most frequently registered combinations of manufacturers of THA compo-
nents in each mixed-component group (n = 18,396)
 Mixed stem-head THA Mixed head-cup THA Mixed stem-head-cup THA
 (n = 3,663) (n = 12,960) (n = 1,773)
 Stem Head n Head Cup n Stem Head Cup n
1 a b 2,623 a b 2,377 f d f 945
2 c d 207 c d 2,147 b a b 92
3 b e 117 c e 867 f h g 63
4 f e 66 g b 753 g a i 32
5 c b 63 c f 631 c f c 23
The letters represent anonymized manufacturers of hip arthroplasty components. 
Table 4. Cumulative incidence of revision in THAs performed in the 
period 2007–2014 in the Netherlands (n = 161,360)
 Non-mixed THA Mixed THA a 
Revision for (n = 142,964) (n = 18,396)
any reason: % 95% CI % 95% CI
1 year 1.3 1.3–1.4 1.4 1.2–1.5
6 years 3.5 3.4–3.7 3.4 3.1–3.7
a
 This group includes mixed stem-head THAs, mixed head-cup 
THAs, and mixed stem-head-cup THAs.
Figure 2. Cumulative incidence of revision 
according to category of mixing of THA compo-
nents in the Netherlands in the period 2007–2014 
(n = 161,360)
Years after primary THA
Cumulative revision percentage














Table 5. Reasons for revision or reoperation in revised THAs performed in the period 
2007–2014 in the Netherlands (n = 3,879)
 Non-mixed THA Mixed THA a Total
  (n = 3,403) (n = 476) (n = 3,879)
Revision within 6 years for n % n % n %
Infection 379 11 57 12 436 11
Periprosthetic fracture 450 13 62 13 512 13
Symptomatic MoM b bearing 223 6.6 8 1.7 d 231 6.0
Dislocation 969 29 152 32 1,121 29
Loosening of femur 712 21 84 18 796 21
Loosening of acetabulum 421 12 77 16 c 498 13
Cup/liner wear 119 3.5 16 3.4 135 3.5
Periarticular ossifi cation 71 2.1 14 2.9 85 2.2
Girdlestone 141 4.1 19 4.0 160 4.1
Other 549 16 78 16 627 16
a





 p < 0.05; d p < 0.0001.  
with non-mixed THAs (hazard ratio (HR) = 
0.78, 95% CI: 0.62–0.98) (Table 6). However, 
after adjustment for confounders there was 
no statistically signifi cant difference in revi-
sion rate between the different mixed-compo-
nent groups and non-mixed THAs. Younger 
patients (< 60 years), those with previous 
operation of the affected hip, patients with an 
ASA score of II–IV,  those with a diagnosis 
other than osteoarthritis—and also those with 
a reversed hybrid THA, a small femoral head 
component (22–28 mm), a large femoral head 
component (≥ 38 mm), a metal-on-metal or 
metal-on-polyethylene articulation, or a THA 
implanted in the period 2012–2014 were more 
frequently revised. THAs with cemented 
fi xation and ceramic-on-ceramic articula-
tion resulted in a lower frequency of revision 
(Table 6).
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Table 6. Multivariate survival analysis of patients who underwent 
THA in the period 2007–2014 in the Netherlands (n = 161,360)
 Crude hazard ratio Adjusted hazard 
 for revision (95% CI) ratio a (95% CI)
THA mixing category
   Non-mixed 1.0 1.0
   Mixed stem-head 0.78 (0.62–0.98) b 0.80 (0.63–1.03)
   Mixed head-cup 1.03 (0.92–1.15) 1.11 (0.97–1.27)
   Mixed stem-head-cup 1.01 (0.77–1.31) 1.02 (0.77–1.37)
Age at surgery, years
   < 60 1.42 (1.32–1.54) b 1.20 (1.11–1.31) b
   60–74 1.0 1.0
   ≥ 75 0.84 (0.78–0.91) b 0.93 (0.85–1.01)
Sex
   Male 1.20 (1.13–1.28) b 1.08 (1.01–1.16) b
   Female 1.0 1.0
ASA score
   I 1.0 1.0
   II 0.99 (0.92–1.06) 1.18 (1.09–1.27) b
   III–IV 1.18 (1.06–1.31) b 1.46 (1.31–1.64) b
Diagnosis
   Osteoarthritis 1.0 1.0
   Non-osteoarthritis 1.31 (1.20–1.42) b 1.18 (1.07–1.29) b
Previous operation
   No 1.0 1.0
   Yes 1.36 (1.20–1.54) b 1.19 (1.08–1.32) b
Fixation
   Cementless 1.0 1.0
   Hybrid 0.72 (0.61–0.85) b 0.78 (0.65–0.94)
   Cemented 0.58 (0.53–0.63) b 0.63 (0.57–0.69) b
   Reversed hybrid 1.19 (1.03–1.37) b 1.17 (0.99–1.37)
   Unknown 1.21 (0.58–2.54) 1.18 (0.44–3.14)
Diameter of head 
   22–28 mm 1.07 (0.99–1.15) 1.12 (1.03–1.21) b
   32 mm 1.0 1.0
   36 mm 1.15 (1.04–1.27) 1.11 (0.99–1.23)
   ≥ 38 mm 4.23 (3.78–4.73) b 2.86 (2.44–3.35) b
Articulation
   Metal-on-metal 2.92 (2.65–3.22) b 1.71 (1.49–1.97) b
   Metal-on-PE 1.01 (0.94–1.09) 1.16 (1.07–1.26) b
   Ceramic-on-PE 1.0 1.0
   Ceramic-on-ceramic 1.04 (0.92–1.18) 0.88 (0.77–1.01)
   Other 0.82 (0.69–0.97) b  0.93 (0.78–1.11)
Period
   2007–2009 1.14 (1.05–1.23) b 1.06 (0.97–1.15)
   2010–2011 1.0 1.0
   2012–2014 1.16 (1.06–1.26) b 1.28 (1.17–1.40) b
a
 Adjusted for age at surgery, gender, ASA score, diagnosis, previ-
ous operation, fi xation, head diameter, articulation, and period.
b
 p < 0.0001.
Discussion
There is an ongoing debate about the use of components from 
different manufacturers in assembling a total hip arthroplasty. 
Based on a nationwide register, we found similar short-term 
survival of mixed and non-mixed THAs. These fi ndings are 
supported by recent research from the NJR of England and 
Wales, in which even lower revision rates were found in 
patients with mixed cemented stems with polyethylene cups 
from another manufacturer (Tucker et al. 2015).
It has been hypothesized that mixing and matching of com-
ponents from different manufacturers can lead to adverse 
effects due to unforeseen size mismatching of heads and tapers, 
and between heads and cups (Ljung et al. 1989, Barrack et al. 
1993, Morlock et al. 2001, Andrew et al. 2008). Moreover, 
mixing and matching of components from different manufac-
turers may result in an alloy mismatch (Morlock et al. 2001). 
Recent awareness of taper corrosion has revealed that dissimi-
lar alloy pairing is associated with increased taper damage at 
the modular interfaces (Higgs et al. 2013). Although ceramic 
femoral heads on metal tapers appear to reduce taper fretting 
corrosion compared to metal heads (Kurtz et al. 2013), there 
is very little literature on the long-term results. However, the 
recent research from the NJR of England and Wales revealed 
that mixing of a cemented stem with a polyethylene cup from 
a different manufacturer did not result in higher revision rates 
(Tucker et al. 2015).
Our registry study should be considered in the light of having 
certain limitations. First of all, the validity of the LROI has 
not been 100% since its introduction, but has been improving 
over the years. The validity of the registry increased from 88% 
completeness for THAs in 2009 to 98% in 2012 (van Steen-
bergen et al. 2015). Secondly, patient-reported outcome mea-
sures (PROMs) will be reported  in the very near future, and 
the LROI does not yet report on surgeon experience. Retrieval 
analysis is the only method of confi rming size mismatch, and 
may therefore be underrepresented in national joint registries 
that record the diagnosis for revision at the time of revision. 
Finally, our study had a limited follow-up time of 8 years. We 
acknowledge that possible complications of mixing compo-
nents of different manufacturers, e.g. osteolysis, may have 
resulted in adverse events that would not be detected within 
the 8-year follow-up period. 
Revision of primary THAs due to loosening of the acetab-
ulum appeared to be more common in mixed THAs. Theo-
retically, loosening of components in the mixed-component 
group may be explained by increased trunnion wear due to a 
taper mismatch. 
Manufacturers generally issue warnings and precautions 
regarding their products, cautioning against mixing of compo-
nents from different manufacturers. However, surgeons prefer 
combinations that have the highest Orthopaedic Data Evalu-
ation Panel (ODEP) rating, but will ask for combinations to 
fulfi ll certain criteria that may not be within the reach of many 
manufacturers. For example, a cemented stem suitable for an 
anterior approach combined with an uncemented cup with a 
bearing type that is only possible by combining one manufac-
turer’s highly ODEP-rated cup with a stem from a competitor. 
However, the question remains as to whether this is allowable 
by law. Orthopedic surgeons should comply with all the reg-
ulations that are set by manufacturers—such as instructions 
for product surveillance, vigilance, and maintenance to avoid 
restrictions based on civil law (Michel 2009). Legally, a THA 
that has been tested for its confi guration and has been approved 
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by a declaration of conformity is modifi ed when components 
from different manufacturers are mixed. With the replacement 
or substitution of an incompatible component, the declaration 
of conformity of the original manufacturer expires (Michel 
2009). The implications of these laws are not foreseeable yet, 
but surgeons should be cautioned to check whether mixing of 
the products is not restricted in the precaution sheets of the 
prostheses they use. With the recent merger of Biomet and 
Zimmer, and the manufacture of ceramic heads for several dif-
ferent companies by CeramTec, extra care should be applied 
to interpretation of the precaution sheets for newly released 
prosthesis combinations.  
Mixed THAs are also described as off-label arthroplasties. 
“Offl abel use” refers to use of medical devices for purposes 
or subpopulations other than those approved by the United 
States Food and Drug Administration (Malcolm et al. 2015). 
Malcolm et al. (2015) demonstrated that the prevalence of off-
label THAs and TKAs was 30% and 37%, respectively, in the 
USA. They predicted an increase in the prevalence of off-label 
arthroplasties in the future. Tucker et al. (2015) described over 
90,000 cases recorded between 2003 and 2013. In half of these 
cases, stems and heads from one manufacturer were mixed 
with a polyethylene cemented cup from another manufacturer. 
These numbers emphasize the differences between countries 
regarding the frequency of mixing of different components, 
as only 1% of the Dutch implants are used with this mixed 
combination. 
The use of different taper sizes by the different manufactur-
ers has made it diffi cult for surgeons to combine the right com-
bination of stem and head junction, especially in revision hip 
arthroplasty. Manufacturers often have extensive overviews of 
which stems (male taper) can be combined with which heads 
(female taper), as these may differ in shape, roughness, incli-
nation, and angle (Werner et al. 2015). Another issue is that 
manufacturers have changed tapers over the years in the same 
stem, e.g. Omnifi t stems produced before the year 1991 had a 
Morse taper, but nowadays they have a C-taper (D’Lima et al. 
1999). With very few literature overviews on taper dimensions 
of components, more research efforts towards unraveling the 
clinical signifi cance of the potential mismatches are required. 
In conclusion, 11% of THAs in the Netherlands were com-
posed of mixed components, with similar medium-term revi-
sion rates to those of non-mixed THAs. Further studies on the 
use of mixed components in THA are needed, and they should 
be performed with a similar nationwide or international cohort 
with long-term follow-up. 
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